Literature DB >> 20858755

Maintenance of the thyroid axis during diet-induced obesity in rodents is controlled at the central level.

Mario Perello1, Isin Cakir, Nicole E Cyr, Amparo Romero, Ronald C Stuart, Franck Chiappini, Anthony N Hollenberg, Eduardo A Nillni.   

Abstract

The hypothalamic-pituitary-thyroid (HPT) axis is a major contributor in maintaining energy expenditure and body weight, and the adipocyte hormone leptin regulates this axis by increasing TRH levels in the fed state. Leptin stimulates TRH directly in the hypothalamic paraventricular nucleus (PVN; direct pathway) and indirectly by regulating proopiomelnocortin neurons in the hypothalamic arcuate nucleus (ARC; indirect pathway). Whereas the indirect pathway is fully functional in lean animals, it is inactive during diet-induced obesity (DIO) because of the establishment of leptin resistance. Despite this, the HPT axis activity in obese humans and rodents remains within the normal levels or slightly higher. Therefore, in this study, we aimed to determine the mechanism(s) by which the HPT axis is still active despite leptin resistance. With a combination of using the Sprague-Dawley rat physiological model and the Zuker rat that bears a mutation in the leptin receptor, we were able to demonstrate that under DIO conditions the HPT axis is regulated at the central level, but only through the direct pathway of leptin action on TRH neurons. Deiodinase enzymes, which are present in many tissues and responsible for converting thyroid hormones, were not statistically different between lean and DIO animals. These data suggest that the increase in T(4/3) seen in obese animals is due mostly to central leptin action. We also found that T(3) feedback inhibition on the prepro-TRH gene is controlled partially by leptin-induced pSTAT3 signaling via the TRH promoter. This interactive relationship between T(3) and pSTAT3 signaling appears essential to maintain the HPT axis at normal levels in conditions such as obesity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858755      PMCID: PMC3006258          DOI: 10.1152/ajpendo.00448.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  61 in total

1.  Thyroid status of obese (ob/ob) mice and its relationship to adipose tissue metabolism.

Authors:  D A York; W Otto; T G Taylor
Journal:  Comp Biochem Physiol B       Date:  1978

2.  Triiodothyronine amplifies norepinephrine stimulation of uncoupling protein gene transcription by a mechanism not requiring protein synthesis.

Authors:  A C Bianco; X Y Sheng; J E Silva
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

3.  Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4), 3,5,3'-L-triiodothyronine (T3), 3,3',5'-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, alpha 2-haptoglobin and complement C'3 in serum.

Authors:  P C Scriba; M Bauer; D Emmert; A Fateh-Moghadam; G G Hofmann; K Horn; C R Pickardt
Journal:  Acta Endocrinol (Copenh)       Date:  1979-08

4.  Region-specific leptin resistance within the hypothalamus of diet-induced obese mice.

Authors:  Heike Münzberg; Jeffrey S Flier; Christian Bjørbaek
Journal:  Endocrinology       Date:  2004-07-22       Impact factor: 4.736

5.  Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis.

Authors:  Nina Balthasar; Roberto Coppari; Julie McMinn; Shun M Liu; Charlotte E Lee; Vinsee Tang; Christopher D Kenny; Robert A McGovern; Streamson C Chua; Joel K Elmquist; Bradford B Lowell
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

6.  Leptin signaling targets the thyrotropin-releasing hormone gene promoter in vivo.

Authors:  Feifan Guo; Keren Bakal; Yasuhiko Minokoshi; Anthony N Hollenberg
Journal:  Endocrinology       Date:  2004-02-05       Impact factor: 4.736

7.  Disparity of thyrotropin (TSH) and prolactin responses to TSH-releasing hormone in obesity.

Authors:  S H Donders; G F Pieters; J G Heevel; H A Ross; A G Smals; P W Kloppenborg
Journal:  J Clin Endocrinol Metab       Date:  1985-07       Impact factor: 5.958

8.  Thyroid and obesity: survey of some function tests in a large obese population.

Authors:  A Strata; G Ugolotti; C Contini; G Magnati; C Pugnoli; F Tirelli; U Zuliani
Journal:  Int J Obes       Date:  1978

9.  The little (lit) mutation cosegregates with the growth hormone releasing factor receptor on mouse chromosome 6.

Authors:  S C Chua; K Hennessey; P Zeitler; R L Leibel
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

10.  Dietary-induced alterations in thyroid hormone metabolism during overnutrition.

Authors:  E Danforth; E S Horton; M O'Connell; E A Sims; A G Burger; S H Ingbar; L Braverman; A G Vagenakis
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

View more
  30 in total

1.  Deletion of p22phox-dependent oxidative stress in the hypothalamus protects against obesity by modulating β3-adrenergic mechanisms.

Authors:  Heinrich E Lob; Jiunn Song; Chansol Hurr; Alvin Chung; Colin N Young; Allyn L Mark; Robin L Davisson
Journal:  JCI Insight       Date:  2017-01-26

2.  The Nutrient and Energy Sensor Sirt1 Regulates the Hypothalamic-Pituitary-Adrenal (HPA) Axis by Altering the Production of the Prohormone Convertase 2 (PC2) Essential in the Maturation of Corticotropin-releasing Hormone (CRH) from Its Prohormone in Male Rats.

Authors:  Anika M Toorie; Nicole E Cyr; Jennifer S Steger; Ross Beckman; George Farah; Eduardo A Nillni
Journal:  J Biol Chem       Date:  2016-01-11       Impact factor: 5.157

3.  Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats.

Authors:  Helge Müller-Fielitz; Margot Lau; Cathleen Geißler; Lars Werner; Martina Winkler; Walter Raasch
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

Review 4.  Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions.

Authors:  Csaba Fekete; Ronald M Lechan
Journal:  Endocr Rev       Date:  2013-12-13       Impact factor: 19.871

5.  NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways.

Authors:  Kristen R Vella; Preeti Ramadoss; Francis S Lam; Jamie C Harris; Felix D Ye; Paul D Same; Nicholas F O'Neill; Eleftheria Maratos-Flier; Anthony N Hollenberg
Journal:  Cell Metab       Date:  2011-11-17       Impact factor: 27.287

6.  Evaluation of the relationship of subclinical hypothyroidism with metabolic syndrome and its components in adolescents: a population-based study.

Authors:  Min-Kyung Lee; Yoo Mee Kim; Seo-Young Sohn; Jae-Hyuk Lee; Young Jun Won; Se Hwa Kim
Journal:  Endocrine       Date:  2019-05-01       Impact factor: 3.633

7.  Triiodothyronine and leptin repletion in humans similarly reverse weight-loss-induced changes in skeletal muscle.

Authors:  Michael Rosenbaum; Rochelle L Goldsmith; Fadia Haddad; Kenneth M Baldwin; Richard Smiley; Dympna Gallagher; Rudolph L Leibel
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-06-19       Impact factor: 4.310

8.  Central Sirt1 regulates body weight and energy expenditure along with the POMC-derived peptide α-MSH and the processing enzyme CPE production in diet-induced obese male rats.

Authors:  Nicole E Cyr; Jennifer S Steger; Anika M Toorie; Jonathan Z Yang; Ronald Stuart; Eduardo A Nillni
Journal:  Endocrinology       Date:  2014-04-28       Impact factor: 4.736

9.  Mechanisms by which the orexigen NPY regulates anorexigenic α-MSH and TRH.

Authors:  Nicole E Cyr; Anika M Toorie; Jennifer S Steger; Matthew M Sochat; Samantha Hyner; Mario Perello; Ronald Stuart; Eduardo A Nillni
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

10.  Family members CREB and CREM control thyrotropin-releasing hormone (TRH) expression in the hypothalamus.

Authors:  Franck Chiappini; Preeti Ramadoss; Kristen R Vella; Lucas L Cunha; Felix D Ye; Ronald C Stuart; Eduardo A Nillni; Anthony N Hollenberg
Journal:  Mol Cell Endocrinol       Date:  2012-09-20       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.